Literature DB >> 4903692

Clinical antidepressant activity of cyclazocine--a narcotic antagonist.

M Fink, J Simeon, T M Itil, A M Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4903692     DOI： 10.1002/cpt197011141

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Proceedings: The effects of RX 336M and RX 5050M on tests for antidepressant activity in mice.

Authors:  N S Doggett; H Reno; P S Spencer
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

2.  Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal.

Authors:  S Borg; H Kvande; U Rydberg; L Terenius; A Wahlström
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.

Authors:  Pattipati S Naidu; Aron H Lichtman; Carey C Archer; Everett L May; Louis S Harris; Mario D Aceto
Journal:  Eur J Pharmacol       Date:  2007-03-30       Impact factor: 4.432

4.  Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.

Authors:  Jordan F Karp; Meryl A Butters; Amy E Begley; Mark D Miller; Eric J Lenze; Daniel M Blumberger; Benoit H Mulsant; Charles F Reynolds
Journal:  J Clin Psychiatry       Date:  2014-08       Impact factor: 4.384
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.